Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Abstract Background Despite growing concerns about young people’s mental health, it remains unclear how rates of psychiatric diagnoses and psychotropic medication prescribing have changed. Aim To investigate temporal trends in UK primary care-recorded incidence of (1) psychiatric diagnoses: attention deficit hyperactivity disorders (ADHD), autism spectrum conditions, anxiety disorders, depression, substance misuse, and personality disorders, and (2) psychotropic medication prescribing, in individuals aged 1–24 years. Design and setting This was a population-based study using primary care data from the Clinical Practice Research Datalink. Method The monthly incidence of each outcome from January 2010 to March 2022 were calculated. Negative binomial regression was used to predict expected incidence rates when the COVID-19 pandemic began in March 2020, based on antecedent trends. Observed and predicted (that is, expected) rates were compared. Results In the 2 years following March 2020, the incidence of ADHD diagnoses in females was 24.7% (95% confidence interval = 11.9 to 38.9%) greater than the expected incidence rate predicted from the trends before the pandemic. The increase in ADHD diagnoses occurred more commonly for females aged 20–24 years, followed by those aged 17–19 years, as well as among females from less deprived areas. Similar trends were observed for ADHD medications. Observed rates of other outcomes, including common mental illnesses, were below or close to the expected levels, with the differentials between observed and expected rates being greater for males than females. Conclusion Increased ADHD awareness may partly explain the study's findings. However, the fall in other diagnoses may reflect barriers to accessing health services at the height of the pandemic. Early identification and timely treatment of mental health difficulties and neurodevelopmental conditions are crucial.

More information Original publication

DOI

https://doi.org/10.3399/BJGP.2024.0804

Type

Journal article

Journal

BJGP Open

Issue

British Journal of General Practice 2025; 75 (758): e566-e576.

Publisher

British Journal of General Practice

Publication Date

28/08/2025

Addresses

Pearl LH Mok was funded by the National Institute for Health and Care Research (NIHR) School for Primary Care Research (reference number 566)

Keywords

ADHD, COVID-19, mental health, patient involvement, primary health care